Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aurora Kinase A | 27 | 2024 | 202 | 2.980 |
Why?
|
Pancreatic Neoplasms | 25 | 2023 | 5061 | 1.900 |
Why?
|
Carcinoma, Pancreatic Ductal | 14 | 2023 | 1724 | 1.870 |
Why?
|
MicroRNAs | 11 | 2021 | 2947 | 1.570 |
Why?
|
Aurora Kinases | 33 | 2013 | 189 | 1.470 |
Why?
|
Aurora Kinase C | 5 | 2016 | 11 | 1.330 |
Why?
|
Mammary Neoplasms, Animal | 2 | 2024 | 221 | 1.320 |
Why?
|
Cell Transformation, Neoplastic | 14 | 2015 | 2359 | 1.210 |
Why?
|
CA-19-9 Antigen | 5 | 2023 | 144 | 1.100 |
Why?
|
Biomarkers, Tumor | 20 | 2023 | 10331 | 0.980 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2024 | 28 | 0.970 |
Why?
|
Aurora Kinase B | 7 | 2020 | 68 | 0.950 |
Why?
|
Adenocarcinoma, Mucinous | 3 | 2022 | 436 | 0.880 |
Why?
|
Chromosomal Instability | 4 | 2020 | 233 | 0.860 |
Why?
|
Extracellular Vesicles | 1 | 2023 | 135 | 0.800 |
Why?
|
Aneuploidy | 8 | 2008 | 369 | 0.780 |
Why?
|
Gene Expression Regulation, Neoplastic | 20 | 2020 | 8873 | 0.740 |
Why?
|
Centrosome | 6 | 2023 | 95 | 0.700 |
Why?
|
Mitosis | 11 | 2023 | 615 | 0.660 |
Why?
|
PTEN Phosphohydrolase | 1 | 2024 | 986 | 0.660 |
Why?
|
Neoplasms | 10 | 2017 | 15193 | 0.610 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2016 | 202 | 0.610 |
Why?
|
Chromosomal Proteins, Non-Histone | 3 | 2016 | 362 | 0.590 |
Why?
|
Breast Neoplasms | 14 | 2024 | 15694 | 0.560 |
Why?
|
Phosphonoacetic Acid | 1 | 2015 | 18 | 0.540 |
Why?
|
Cyclin A | 1 | 2015 | 47 | 0.530 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 1258 | 0.520 |
Why?
|
Aspartic Acid | 1 | 2015 | 126 | 0.510 |
Why?
|
Cyst Fluid | 1 | 2014 | 21 | 0.510 |
Why?
|
Cell Communication | 1 | 2017 | 509 | 0.510 |
Why?
|
HeLa Cells | 12 | 2016 | 1643 | 0.500 |
Why?
|
Cyclin-Dependent Kinase 2 | 2 | 2015 | 249 | 0.490 |
Why?
|
Pancreatic Cyst | 1 | 2014 | 107 | 0.460 |
Why?
|
CpG Islands | 1 | 2015 | 633 | 0.440 |
Why?
|
M Phase Cell Cycle Checkpoints | 1 | 2012 | 29 | 0.420 |
Why?
|
Phosphorylation | 13 | 2016 | 4804 | 0.410 |
Why?
|
Humans | 90 | 2024 | 261506 | 0.400 |
Why?
|
Chromosome Aberrations | 6 | 2010 | 1960 | 0.400 |
Why?
|
Testis | 2 | 2015 | 717 | 0.400 |
Why?
|
Tumor Suppressor Proteins | 4 | 2013 | 1823 | 0.400 |
Why?
|
Kinetochores | 2 | 2008 | 23 | 0.400 |
Why?
|
Cell Division | 5 | 2012 | 2489 | 0.380 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 1547 | 0.380 |
Why?
|
Genes, p53 | 3 | 2005 | 1090 | 0.360 |
Why?
|
Neoplasm Metastasis | 4 | 2017 | 5112 | 0.350 |
Why?
|
Gene Amplification | 9 | 2008 | 731 | 0.350 |
Why?
|
Estrogen Receptor alpha | 2 | 2011 | 701 | 0.340 |
Why?
|
GATA3 Transcription Factor | 1 | 2010 | 146 | 0.340 |
Why?
|
Adenocarcinoma | 7 | 2016 | 7789 | 0.330 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2015 | 1299 | 0.330 |
Why?
|
Nuclear Proteins | 3 | 2012 | 3343 | 0.330 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2011 | 3552 | 0.330 |
Why?
|
G2 Phase | 6 | 2007 | 206 | 0.330 |
Why?
|
Tumor Cells, Cultured | 13 | 2012 | 5395 | 0.320 |
Why?
|
Genomic Instability | 4 | 2013 | 519 | 0.310 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5178 | 0.310 |
Why?
|
Apoptosis | 10 | 2015 | 7591 | 0.310 |
Why?
|
Animals | 39 | 2024 | 59536 | 0.300 |
Why?
|
Microtubules | 1 | 2008 | 270 | 0.300 |
Why?
|
Cell Line, Tumor | 19 | 2023 | 14551 | 0.290 |
Why?
|
Protein Binding | 7 | 2020 | 3438 | 0.280 |
Why?
|
Chromosomes, Human | 2 | 2004 | 295 | 0.280 |
Why?
|
Cell Cycle | 10 | 2010 | 2084 | 0.280 |
Why?
|
RNA, Messenger | 14 | 2014 | 6150 | 0.280 |
Why?
|
Chromatin | 3 | 2008 | 942 | 0.280 |
Why?
|
Mice | 24 | 2024 | 34495 | 0.270 |
Why?
|
Chromosomes, Human, Pair 20 | 3 | 2004 | 64 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 6 | 2016 | 5539 | 0.260 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 2291 | 0.260 |
Why?
|
DNA Damage | 3 | 2012 | 1954 | 0.260 |
Why?
|
DNA Methylation | 1 | 2015 | 2669 | 0.260 |
Why?
|
ROC Curve | 3 | 2021 | 1183 | 0.250 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2016 | 4549 | 0.250 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 8 | 2014 | 3639 | 0.250 |
Why?
|
F-Box-WD Repeat-Containing Protein 7 | 1 | 2024 | 83 | 0.240 |
Why?
|
Signal Transduction | 5 | 2020 | 11965 | 0.240 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2024 | 163 | 0.230 |
Why?
|
Extrachromosomal Inheritance | 2 | 1994 | 4 | 0.230 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 2864 | 0.230 |
Why?
|
Pancreatic Stellate Cells | 1 | 2023 | 76 | 0.230 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2023 | 108 | 0.220 |
Why?
|
Real-Time Polymerase Chain Reaction | 3 | 2015 | 1217 | 0.220 |
Why?
|
Immunoprecipitation | 2 | 2016 | 591 | 0.220 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 2195 | 0.210 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2013 | 317 | 0.210 |
Why?
|
DNA, Neoplasm | 6 | 2011 | 1910 | 0.210 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2023 | 360 | 0.210 |
Why?
|
Cigarette Smoking | 1 | 2023 | 88 | 0.210 |
Why?
|
Case-Control Studies | 8 | 2021 | 6100 | 0.200 |
Why?
|
Carcinoma | 2 | 2011 | 2578 | 0.200 |
Why?
|
Carcinoma in Situ | 3 | 2020 | 487 | 0.200 |
Why?
|
RNA, Long Noncoding | 2 | 2020 | 598 | 0.200 |
Why?
|
DNA-Binding Proteins | 2 | 2012 | 4821 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 3 | 2015 | 4757 | 0.200 |
Why?
|
Female | 39 | 2024 | 141928 | 0.200 |
Why?
|
Chalcone | 1 | 2020 | 3 | 0.200 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2010 | 703 | 0.200 |
Why?
|
Benzophenones | 1 | 2020 | 12 | 0.190 |
Why?
|
Feasibility Studies | 2 | 2021 | 2292 | 0.190 |
Why?
|
Feedback | 1 | 2001 | 198 | 0.190 |
Why?
|
Tubulin Modulators | 1 | 2020 | 65 | 0.190 |
Why?
|
Blood Specimen Collection | 1 | 2021 | 93 | 0.190 |
Why?
|
Datasets as Topic | 1 | 2021 | 181 | 0.190 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2020 | 624 | 0.190 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 973 | 0.180 |
Why?
|
Neoplasms, Experimental | 2 | 2020 | 750 | 0.180 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2001 | 214 | 0.180 |
Why?
|
Transfection | 7 | 2011 | 2944 | 0.180 |
Why?
|
Up-Regulation | 4 | 2015 | 2450 | 0.180 |
Why?
|
Amino Acid Sequence | 4 | 2016 | 4233 | 0.180 |
Why?
|
Tenascin | 2 | 2017 | 56 | 0.180 |
Why?
|
BRCA2 Protein | 2 | 2013 | 358 | 0.170 |
Why?
|
Gene Expression Profiling | 5 | 2013 | 5159 | 0.170 |
Why?
|
Molecular Sequence Data | 8 | 2003 | 6089 | 0.170 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 14289 | 0.170 |
Why?
|
Pancreas | 2 | 2021 | 718 | 0.170 |
Why?
|
Cytokinesis | 2 | 2016 | 57 | 0.170 |
Why?
|
Tubulin | 4 | 2020 | 169 | 0.170 |
Why?
|
Fibroblasts | 2 | 2004 | 1682 | 0.170 |
Why?
|
Heterochromatin | 3 | 1986 | 83 | 0.160 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 27 | 0.160 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 72 | 0.160 |
Why?
|
Models, Biological | 4 | 2016 | 3254 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2010 | 287 | 0.160 |
Why?
|
Chromosomes | 4 | 2003 | 244 | 0.160 |
Why?
|
Neoplasm Proteins | 4 | 2016 | 3230 | 0.160 |
Why?
|
Brain Neoplasms | 1 | 2015 | 4849 | 0.160 |
Why?
|
In Situ Hybridization, Fluorescence | 9 | 2010 | 2232 | 0.160 |
Why?
|
Lipoproteins | 2 | 2017 | 252 | 0.160 |
Why?
|
Spindle Apparatus | 3 | 2023 | 93 | 0.160 |
Why?
|
Gene Expression Regulation | 3 | 2004 | 4053 | 0.160 |
Why?
|
Phenylalanine-tRNA Ligase | 1 | 1997 | 3 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2010 | 528 | 0.150 |
Why?
|
Ovarian Neoplasms | 3 | 2013 | 4638 | 0.150 |
Why?
|
Polymerase Chain Reaction | 6 | 2008 | 3203 | 0.150 |
Why?
|
Mouth Neoplasms | 2 | 2020 | 713 | 0.150 |
Why?
|
Gene Silencing | 3 | 2016 | 837 | 0.150 |
Why?
|
Centrifugation, Density Gradient | 1 | 2016 | 124 | 0.140 |
Why?
|
Promoter Regions, Genetic | 3 | 2015 | 3101 | 0.140 |
Why?
|
Phosphoserine | 1 | 2016 | 107 | 0.140 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2020 | 566 | 0.140 |
Why?
|
Polymorphism, Genetic | 4 | 2011 | 1450 | 0.140 |
Why?
|
Chromosome Segregation | 1 | 2016 | 82 | 0.140 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2008 | 2341 | 0.140 |
Why?
|
Metabolome | 1 | 2019 | 344 | 0.140 |
Why?
|
Mice, Nude | 5 | 2015 | 4307 | 0.140 |
Why?
|
Fluorescent Antibody Technique | 2 | 2011 | 1062 | 0.140 |
Why?
|
Metabolomics | 1 | 2019 | 478 | 0.130 |
Why?
|
Protein Stability | 1 | 2016 | 370 | 0.130 |
Why?
|
Chromosome Mapping | 4 | 1997 | 1471 | 0.130 |
Why?
|
Protein Domains | 1 | 2016 | 314 | 0.130 |
Why?
|
Indoles | 1 | 2020 | 1009 | 0.130 |
Why?
|
Conserved Sequence | 1 | 2016 | 469 | 0.130 |
Why?
|
Transcriptional Activation | 2 | 2011 | 1070 | 0.130 |
Why?
|
Exosomes | 1 | 2017 | 253 | 0.130 |
Why?
|
Tumor Protein p73 | 2 | 2012 | 105 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 1 | 2003 | 2488 | 0.120 |
Why?
|
Sensitivity and Specificity | 6 | 2020 | 4971 | 0.120 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 984 | 0.120 |
Why?
|
Cell Proliferation | 7 | 2020 | 7226 | 0.120 |
Why?
|
Male | 23 | 2021 | 123000 | 0.120 |
Why?
|
Cytokines | 1 | 2023 | 2809 | 0.120 |
Why?
|
Epithelium | 1 | 2016 | 720 | 0.120 |
Why?
|
Carcinogenesis | 2 | 2020 | 1026 | 0.120 |
Why?
|
Cytogenetic Analysis | 2 | 2020 | 568 | 0.120 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2003 | 997 | 0.120 |
Why?
|
Proteins | 2 | 2013 | 1963 | 0.120 |
Why?
|
Indazoles | 1 | 2015 | 297 | 0.120 |
Why?
|
Prognosis | 9 | 2014 | 21713 | 0.120 |
Why?
|
Receptors, Endothelin | 1 | 2013 | 24 | 0.120 |
Why?
|
Receptors, Angiotensin | 1 | 2013 | 44 | 0.120 |
Why?
|
Genes, Retinoblastoma | 1 | 1993 | 86 | 0.120 |
Why?
|
DNA, Complementary | 3 | 2007 | 869 | 0.110 |
Why?
|
RNA, Small Interfering | 4 | 2009 | 2216 | 0.110 |
Why?
|
Retinoblastoma Protein | 2 | 1998 | 335 | 0.110 |
Why?
|
Blotting, Southern | 4 | 2003 | 406 | 0.110 |
Why?
|
Lung Neoplasms | 2 | 2015 | 11538 | 0.110 |
Why?
|
Blotting, Western | 6 | 2013 | 3536 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2021 | 29902 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 1362 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 507 | 0.110 |
Why?
|
Neoplasm Invasiveness | 3 | 2014 | 3981 | 0.110 |
Why?
|
Aged | 15 | 2021 | 70117 | 0.110 |
Why?
|
Mammary Glands, Animal | 1 | 2016 | 533 | 0.110 |
Why?
|
Base Sequence | 8 | 1997 | 4917 | 0.110 |
Why?
|
Leukemia, Myeloid | 2 | 1997 | 941 | 0.110 |
Why?
|
Autoimmune Diseases | 1 | 2016 | 402 | 0.110 |
Why?
|
Middle Aged | 17 | 2021 | 86204 | 0.110 |
Why?
|
DNA, Circular | 1 | 1992 | 34 | 0.100 |
Why?
|
Transcription, Genetic | 4 | 2013 | 3154 | 0.100 |
Why?
|
Genome Components | 1 | 2011 | 4 | 0.100 |
Why?
|
Tobacco, Smokeless | 1 | 2011 | 28 | 0.100 |
Why?
|
Neoplasm Staging | 3 | 2021 | 13658 | 0.100 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2012 | 161 | 0.100 |
Why?
|
Enzymes | 1 | 2011 | 64 | 0.100 |
Why?
|
Leukoplakia, Oral | 1 | 2011 | 70 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2014 | 2027 | 0.100 |
Why?
|
HL-60 Cells | 2 | 2004 | 302 | 0.100 |
Why?
|
Binding Sites | 4 | 2016 | 2171 | 0.100 |
Why?
|
Disease Progression | 4 | 2018 | 6682 | 0.100 |
Why?
|
Glutathione Transferase | 3 | 2007 | 359 | 0.100 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 1994 | 560 | 0.100 |
Why?
|
Actin-Related Protein 2-3 Complex | 1 | 2010 | 16 | 0.100 |
Why?
|
Enzyme Activators | 1 | 2010 | 20 | 0.090 |
Why?
|
Serine | 3 | 2007 | 388 | 0.090 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 1994 | 430 | 0.090 |
Why?
|
Homeopathy | 1 | 2010 | 9 | 0.090 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2011 | 231 | 0.090 |
Why?
|
Drug Resistance | 5 | 1998 | 587 | 0.090 |
Why?
|
Precipitin Tests | 2 | 2007 | 329 | 0.090 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2009 | 852 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 677 | 0.090 |
Why?
|
Oxadiazoles | 1 | 2010 | 57 | 0.090 |
Why?
|
Leupeptins | 1 | 2009 | 68 | 0.090 |
Why?
|
Neoplasm Grading | 1 | 2014 | 1742 | 0.090 |
Why?
|
Gene Expression | 4 | 2010 | 3570 | 0.090 |
Why?
|
Chromosome Disorders | 2 | 1995 | 417 | 0.090 |
Why?
|
Anaphase | 1 | 2009 | 44 | 0.090 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2009 | 589 | 0.090 |
Why?
|
Protein Kinases | 2 | 2004 | 874 | 0.090 |
Why?
|
Histones | 4 | 2008 | 1466 | 0.090 |
Why?
|
Telomere | 3 | 2010 | 505 | 0.090 |
Why?
|
Phytotherapy | 1 | 2010 | 110 | 0.090 |
Why?
|
Benzodiazepines | 1 | 2010 | 170 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 607 | 0.080 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2010 | 311 | 0.080 |
Why?
|
Immunohistochemistry | 7 | 2013 | 7548 | 0.080 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2020 | 299 | 0.080 |
Why?
|
ras Proteins | 1 | 2013 | 770 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2008 | 476 | 0.080 |
Why?
|
Proteasome Inhibitors | 1 | 2009 | 231 | 0.080 |
Why?
|
Enzyme Stability | 1 | 2007 | 105 | 0.080 |
Why?
|
Feedback, Physiological | 1 | 2008 | 193 | 0.080 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2008 | 195 | 0.080 |
Why?
|
Protein Structure, Tertiary | 3 | 2010 | 1487 | 0.080 |
Why?
|
Paclitaxel | 2 | 2009 | 1996 | 0.080 |
Why?
|
Enzyme Activation | 2 | 2008 | 1764 | 0.080 |
Why?
|
Cell Line | 9 | 2018 | 5114 | 0.080 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2010 | 665 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2013 | 1130 | 0.080 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2010 | 604 | 0.080 |
Why?
|
Cyclin D1 | 1 | 2010 | 576 | 0.080 |
Why?
|
Gene Library | 1 | 2007 | 294 | 0.070 |
Why?
|
CCAAT-Binding Factor | 1 | 2006 | 34 | 0.070 |
Why?
|
Cyclin B | 1 | 2006 | 63 | 0.070 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 1077 | 0.070 |
Why?
|
Substrate Specificity | 1 | 2007 | 549 | 0.070 |
Why?
|
Liver Neoplasms | 2 | 2014 | 4557 | 0.070 |
Why?
|
Skin | 1 | 2012 | 1259 | 0.070 |
Why?
|
Piperazines | 1 | 2015 | 2101 | 0.070 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 1995 | 2527 | 0.070 |
Why?
|
Muridae | 1 | 1986 | 21 | 0.070 |
Why?
|
Mutation | 8 | 2013 | 15179 | 0.070 |
Why?
|
Xenopus Proteins | 2 | 2004 | 185 | 0.070 |
Why?
|
Adult | 12 | 2021 | 77950 | 0.070 |
Why?
|
Green Fluorescent Proteins | 2 | 2008 | 694 | 0.070 |
Why?
|
Pancreatitis, Chronic | 2 | 2017 | 116 | 0.070 |
Why?
|
Phenotype | 4 | 2018 | 6295 | 0.070 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2015 | 1215 | 0.070 |
Why?
|
Nucleic Acid Hybridization | 6 | 1987 | 542 | 0.070 |
Why?
|
Microtubule-Associated Proteins | 1 | 2008 | 534 | 0.070 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1985 | 41 | 0.070 |
Why?
|
Genetic Vectors | 2 | 2007 | 1694 | 0.070 |
Why?
|
Cricetinae | 6 | 1999 | 706 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 2063 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 1390 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 3578 | 0.060 |
Why?
|
Centromere | 1 | 2004 | 97 | 0.060 |
Why?
|
Point Mutation | 2 | 2000 | 769 | 0.060 |
Why?
|
Young Adult | 2 | 2021 | 21445 | 0.060 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 1998 | 402 | 0.060 |
Why?
|
MCF-7 Cells | 2 | 2018 | 550 | 0.060 |
Why?
|
Cloning, Molecular | 3 | 1997 | 1213 | 0.060 |
Why?
|
Blotting, Northern | 2 | 2003 | 682 | 0.060 |
Why?
|
DNA | 4 | 1999 | 2693 | 0.060 |
Why?
|
ras-GRF1 | 1 | 2003 | 8 | 0.060 |
Why?
|
Karyotyping | 5 | 1992 | 1022 | 0.060 |
Why?
|
Pregnancy | 1 | 2016 | 7573 | 0.060 |
Why?
|
Genotype | 4 | 2016 | 4109 | 0.060 |
Why?
|
Mitochondria | 1 | 2010 | 1282 | 0.060 |
Why?
|
Cyclin D2 | 1 | 2023 | 40 | 0.060 |
Why?
|
Urothelium | 1 | 2004 | 254 | 0.060 |
Why?
|
Cell Differentiation | 3 | 2012 | 4078 | 0.060 |
Why?
|
Germinoma | 1 | 2003 | 84 | 0.060 |
Why?
|
Luminescent Proteins | 1 | 2003 | 289 | 0.060 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2007 | 469 | 0.060 |
Why?
|
Cell Movement | 1 | 2010 | 2466 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 7702 | 0.050 |
Why?
|
Flow Cytometry | 5 | 2010 | 3033 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2020 | 810 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 2086 | 0.050 |
Why?
|
Breast | 1 | 2009 | 1344 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 1555 | 0.050 |
Why?
|
Sex Chromosomes | 1 | 1982 | 43 | 0.050 |
Why?
|
Tripartite Motif Proteins | 2 | 2013 | 55 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1998 | 239 | 0.050 |
Why?
|
Protein Phosphatase 1 | 1 | 2001 | 79 | 0.050 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2008 | 962 | 0.050 |
Why?
|
Rats | 1 | 2010 | 6086 | 0.050 |
Why?
|
Colchicine | 1 | 2020 | 52 | 0.050 |
Why?
|
DNA Probes | 3 | 1999 | 217 | 0.050 |
Why?
|
X Chromosome | 1 | 1982 | 339 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2009 | 5437 | 0.050 |
Why?
|
BRCA1 Protein | 1 | 2004 | 493 | 0.050 |
Why?
|
Glycolysis | 2 | 2019 | 519 | 0.050 |
Why?
|
Azoxymethane | 1 | 2020 | 43 | 0.050 |
Why?
|
DNA Replication | 2 | 1982 | 744 | 0.050 |
Why?
|
Dextrans | 1 | 2020 | 90 | 0.050 |
Why?
|
Osteosarcoma | 1 | 2007 | 929 | 0.050 |
Why?
|
Hedgehog Proteins | 1 | 2023 | 424 | 0.050 |
Why?
|
DNA, Satellite | 1 | 1980 | 36 | 0.050 |
Why?
|
Keratinocytes | 2 | 2012 | 241 | 0.050 |
Why?
|
Molecular Docking Simulation | 1 | 2020 | 144 | 0.050 |
Why?
|
Epithelial Cells | 2 | 2023 | 1818 | 0.050 |
Why?
|
India | 2 | 2011 | 301 | 0.050 |
Why?
|
DNA Primers | 2 | 2008 | 1399 | 0.040 |
Why?
|
Primary Cell Culture | 1 | 2020 | 208 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2020 | 227 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2020 | 303 | 0.040 |
Why?
|
Molecular Structure | 1 | 2020 | 515 | 0.040 |
Why?
|
Head and Neck Neoplasms | 2 | 2009 | 3976 | 0.040 |
Why?
|
Carbon Isotopes | 1 | 2020 | 333 | 0.040 |
Why?
|
Hybrid Cells | 2 | 1997 | 128 | 0.040 |
Why?
|
Testicular Neoplasms | 1 | 2003 | 529 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2004 | 2927 | 0.040 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2003 | 674 | 0.040 |
Why?
|
Age Factors | 3 | 2017 | 5377 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 2283 | 0.040 |
Why?
|
Picolinic Acids | 1 | 2018 | 16 | 0.040 |
Why?
|
Chromosome Fragility | 1 | 1998 | 33 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1998 | 189 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2020 | 4143 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 2483 | 0.040 |
Why?
|
Open Reading Frames | 1 | 1998 | 250 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2004 | 2045 | 0.040 |
Why?
|
Benzothiazoles | 1 | 2018 | 94 | 0.040 |
Why?
|
Organoids | 1 | 2020 | 287 | 0.040 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1999 | 362 | 0.040 |
Why?
|
Pyruvic Acid | 1 | 2019 | 133 | 0.040 |
Why?
|
Thermus thermophilus | 1 | 1997 | 13 | 0.040 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1997 | 40 | 0.040 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1997 | 82 | 0.040 |
Why?
|
Gene Frequency | 2 | 2011 | 1163 | 0.040 |
Why?
|
Lactic Acid | 1 | 2019 | 305 | 0.040 |
Why?
|
Rodentia | 1 | 1997 | 65 | 0.040 |
Why?
|
Restriction Mapping | 1 | 1997 | 264 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 376 | 0.040 |
Why?
|
Yeasts | 1 | 1997 | 74 | 0.040 |
Why?
|
Vimentin | 1 | 2018 | 253 | 0.040 |
Why?
|
Postmenopause | 1 | 2019 | 378 | 0.040 |
Why?
|
Risk Assessment | 1 | 2010 | 6869 | 0.040 |
Why?
|
Haplotypes | 2 | 2011 | 856 | 0.040 |
Why?
|
Polyploidy | 2 | 2012 | 73 | 0.040 |
Why?
|
Pilot Projects | 1 | 2023 | 2803 | 0.040 |
Why?
|
Heterografts | 1 | 2019 | 733 | 0.040 |
Why?
|
Antibody Specificity | 1 | 1997 | 334 | 0.040 |
Why?
|
Colon | 1 | 2020 | 670 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 1998 | 602 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2017 | 409 | 0.040 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 2390 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2013 | 854 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 1998 | 769 | 0.030 |
Why?
|
DNA Transposable Elements | 1 | 1997 | 222 | 0.030 |
Why?
|
Time Factors | 3 | 2008 | 12926 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 700 | 0.030 |
Why?
|
Lymphocytes | 2 | 2007 | 1234 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2016 | 246 | 0.030 |
Why?
|
Kinetics | 2 | 2002 | 2049 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 2508 | 0.030 |
Why?
|
Age of Onset | 2 | 2008 | 827 | 0.030 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1995 | 176 | 0.030 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1995 | 6915 | 0.030 |
Why?
|
Mammals | 1 | 1997 | 361 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2007 | 2138 | 0.030 |
Why?
|
Risk Factors | 4 | 2016 | 17523 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1997 | 844 | 0.030 |
Why?
|
Cell Separation | 2 | 2010 | 612 | 0.030 |
Why?
|
Cholestasis | 1 | 2017 | 203 | 0.030 |
Why?
|
Cadherins | 1 | 2018 | 660 | 0.030 |
Why?
|
Alleles | 3 | 2010 | 2437 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2016 | 374 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2015 | 3821 | 0.030 |
Why?
|
Micromanipulation | 1 | 1994 | 10 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 1081 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 1998 | 1064 | 0.030 |
Why?
|
Cohort Studies | 2 | 2017 | 9244 | 0.030 |
Why?
|
Genetic Variation | 3 | 2010 | 2086 | 0.030 |
Why?
|
Antibodies | 1 | 1997 | 838 | 0.030 |
Why?
|
Transcription Factor 7-Like 1 Protein | 1 | 2013 | 31 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2003 | 4844 | 0.030 |
Why?
|
Gene Dosage | 1 | 2016 | 829 | 0.030 |
Why?
|
Snail Family Transcription Factors | 1 | 2013 | 120 | 0.030 |
Why?
|
Keratin-1 | 1 | 2012 | 1 | 0.030 |
Why?
|
Keratins, Hair-Specific | 1 | 2012 | 4 | 0.030 |
Why?
|
Cytogenetics | 1 | 2013 | 149 | 0.030 |
Why?
|
Keratin-14 | 1 | 2012 | 24 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2009 | 4654 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1993 | 261 | 0.030 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2013 | 87 | 0.030 |
Why?
|
Cell Death | 2 | 2009 | 671 | 0.030 |
Why?
|
Smad3 Protein | 1 | 2013 | 129 | 0.030 |
Why?
|
Cricetulus | 3 | 1987 | 205 | 0.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2013 | 153 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2015 | 428 | 0.030 |
Why?
|
Nucleic Acid Denaturation | 1 | 1992 | 34 | 0.030 |
Why?
|
Genes, myc | 1 | 1994 | 358 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1995 | 641 | 0.030 |
Why?
|
Acute Disease | 1 | 2017 | 2422 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2004 | 611 | 0.030 |
Why?
|
Luciferases | 1 | 2013 | 445 | 0.030 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 1992 | 72 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2013 | 327 | 0.030 |
Why?
|
Chromosome Banding | 2 | 1994 | 256 | 0.030 |
Why?
|
Drosophila | 1 | 1997 | 839 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 2173 | 0.030 |
Why?
|
Lung | 1 | 2023 | 3151 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2013 | 1519 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 1994 | 771 | 0.020 |
Why?
|
Smoking | 2 | 2011 | 2440 | 0.020 |
Why?
|
Plasmids | 2 | 2004 | 837 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 10035 | 0.020 |
Why?
|
Metaphase | 2 | 1999 | 107 | 0.020 |
Why?
|
Ubiquitination | 1 | 2013 | 575 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 1994 | 783 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2013 | 501 | 0.020 |
Why?
|
Phytolacca | 1 | 2010 | 3 | 0.020 |
Why?
|
Thuja | 1 | 2010 | 3 | 0.020 |
Why?
|
Conium | 1 | 2010 | 3 | 0.020 |
Why?
|
Wnt Signaling Pathway | 1 | 2013 | 430 | 0.020 |
Why?
|
Subtraction Technique | 1 | 2010 | 141 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 460 | 0.020 |
Why?
|
Micronucleus Tests | 1 | 1989 | 20 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 2011 | 190 | 0.020 |
Why?
|
Computational Biology | 1 | 2016 | 1271 | 0.020 |
Why?
|
Sequence Deletion | 2 | 2006 | 875 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2014 | 1084 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2010 | 367 | 0.020 |
Why?
|
Adenoviridae | 2 | 2006 | 1459 | 0.020 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2009 | 108 | 0.020 |
Why?
|
Papilloma | 1 | 2009 | 74 | 0.020 |
Why?
|
Ethanol | 1 | 2011 | 264 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 15862 | 0.020 |
Why?
|
Cell Nucleus | 2 | 2008 | 1620 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 6942 | 0.020 |
Why?
|
Deoxyribonuclease I | 2 | 1987 | 67 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2013 | 1489 | 0.020 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2010 | 236 | 0.020 |
Why?
|
Vinblastine | 1 | 1989 | 453 | 0.020 |
Why?
|
Ovary | 3 | 1987 | 668 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 1054 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2010 | 548 | 0.020 |
Why?
|
G1 Phase | 1 | 2009 | 285 | 0.020 |
Why?
|
Chickens | 2 | 1987 | 523 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 2314 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2010 | 905 | 0.020 |
Why?
|
Caspases | 1 | 2010 | 661 | 0.020 |
Why?
|
Morphogenesis | 1 | 2009 | 337 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 1489 | 0.020 |
Why?
|
Acetylation | 1 | 2008 | 508 | 0.020 |
Why?
|
Gene Deletion | 1 | 2012 | 1442 | 0.020 |
Why?
|
Cyclin B1 | 1 | 2006 | 56 | 0.020 |
Why?
|
TATA-Box Binding Protein | 1 | 2006 | 38 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 1323 | 0.020 |
Why?
|
Ploidies | 1 | 2007 | 248 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2010 | 584 | 0.020 |
Why?
|
Tetracycline | 1 | 2006 | 90 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 394 | 0.020 |
Why?
|
Genes | 1 | 1987 | 491 | 0.020 |
Why?
|
Cell Survival | 2 | 2010 | 3045 | 0.020 |
Why?
|
Hyaluronan Receptors | 1 | 2007 | 249 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2007 | 298 | 0.020 |
Why?
|
Genomics | 1 | 2016 | 2738 | 0.020 |
Why?
|
Isoenzymes | 2 | 2002 | 614 | 0.020 |
Why?
|
Stem Cells | 1 | 2012 | 1213 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 2007 | 315 | 0.020 |
Why?
|
Doxorubicin | 2 | 1989 | 3005 | 0.020 |
Why?
|
Bortezomib | 1 | 2007 | 543 | 0.020 |
Why?
|
Boronic Acids | 1 | 2007 | 362 | 0.020 |
Why?
|
Leukemia Virus, Murine | 1 | 1984 | 20 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2009 | 10001 | 0.020 |
Why?
|
Odds Ratio | 1 | 2010 | 2316 | 0.020 |
Why?
|
Pancreaticoduodenectomy | 1 | 2008 | 690 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2013 | 5637 | 0.020 |
Why?
|
Thymidine Kinase | 1 | 1985 | 193 | 0.020 |
Why?
|
Cystectomy | 1 | 2008 | 623 | 0.020 |
Why?
|
Biological Evolution | 1 | 1986 | 278 | 0.020 |
Why?
|
Culture Techniques | 1 | 2003 | 132 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 12873 | 0.010 |
Why?
|
Pyrazines | 1 | 2007 | 495 | 0.010 |
Why?
|
Sampling Studies | 1 | 2003 | 170 | 0.010 |
Why?
|
Leydig Cell Tumor | 1 | 2003 | 10 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 2074 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 1491 | 0.010 |
Why?
|
Carcinoma, Embryonal | 1 | 2003 | 29 | 0.010 |
Why?
|
Seminiferous Tubules | 1 | 2003 | 52 | 0.010 |
Why?
|
Endodermal Sinus Tumor | 1 | 2003 | 47 | 0.010 |
Why?
|
DNA Repair | 1 | 2011 | 1872 | 0.010 |
Why?
|
Radiation, Ionizing | 1 | 2004 | 187 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2008 | 2231 | 0.010 |
Why?
|
Leukemia | 1 | 1992 | 1635 | 0.010 |
Why?
|
Seminoma | 1 | 2003 | 81 | 0.010 |
Why?
|
Deoxycytidine | 1 | 2008 | 1353 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2011 | 2265 | 0.010 |
Why?
|
Risk | 1 | 2007 | 1972 | 0.010 |
Why?
|
Atrophy | 1 | 2003 | 261 | 0.010 |
Why?
|
Protamine Kinase | 1 | 2002 | 18 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 886 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2007 | 1038 | 0.010 |
Why?
|
Catalysis | 1 | 2002 | 250 | 0.010 |
Why?
|
p21-Activated Kinases | 1 | 2002 | 122 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 355 | 0.010 |
Why?
|
Germ-Line Mutation | 1 | 2007 | 1046 | 0.010 |
Why?
|
RNA, Viral | 1 | 1984 | 671 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 4938 | 0.010 |
Why?
|
Molecular Weight | 1 | 2002 | 629 | 0.010 |
Why?
|
Cisplatin | 1 | 2008 | 2432 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6207 | 0.010 |
Why?
|
Teratoma | 1 | 2003 | 236 | 0.010 |
Why?
|
Spermatogenesis | 1 | 2003 | 308 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2008 | 3890 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2007 | 1242 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2007 | 1331 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2002 | 663 | 0.010 |
Why?
|
Interphase | 1 | 1999 | 145 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 4988 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2003 | 1363 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 4744 | 0.010 |
Why?
|
Transcription Factors | 1 | 2013 | 5270 | 0.010 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 1999 | 34 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1999 | 198 | 0.010 |
Why?
|
Chromosome Fragile Sites | 1 | 1998 | 38 | 0.010 |
Why?
|
CHO Cells | 1 | 1999 | 311 | 0.010 |
Why?
|
Species Specificity | 1 | 1980 | 777 | 0.010 |
Why?
|
Mastectomy, Segmental | 1 | 2004 | 1026 | 0.010 |
Why?
|
Mastectomy | 1 | 2004 | 1534 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8865 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2003 | 895 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2008 | 4975 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12221 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2010 | 37905 | 0.010 |
Why?
|
Adolescent | 2 | 2007 | 31252 | 0.010 |
Why?
|
Vincristine | 2 | 1986 | 1511 | 0.010 |
Why?
|
Sarcoma, Experimental | 1 | 1992 | 68 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1992 | 185 | 0.010 |
Why?
|
Genetic Markers | 1 | 1994 | 974 | 0.010 |
Why?
|
Heterozygote | 1 | 1994 | 1020 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1992 | 408 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2003 | 8223 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 1992 | 1618 | 0.010 |
Why?
|
Nucleotide Mapping | 1 | 1987 | 24 | 0.000 |
Why?
|
Infant | 1 | 2003 | 13310 | 0.000 |
Why?
|
Immunophenotyping | 1 | 1992 | 1681 | 0.000 |
Why?
|
Demecolcine | 1 | 1986 | 14 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1984 | 117 | 0.000 |
Why?
|
Methylation | 1 | 1984 | 597 | 0.000 |
Why?
|
Transplantation, Heterologous | 1 | 1984 | 1082 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1992 | 7222 | 0.000 |
Why?
|